SARAS CAPITAL β Full Portfolio
9 tracked investments Β· listed companies and verified rows first
kyron.bio develops protein and antibody therapeutics using a glycan-engineering platform that controls glycosylation patterns.
BiotechDeep TechHealthtechParis, FR
Emilia McLaughlin(Cofounder)in
Co-investorsEntrepreneur FirstHCVCVerve VenturesGSV Ventures
NanoSyrinx develops a technology platform for biopharmaceutical applications, with expertise in drug discovery, cell therapy, and biologic development.
AI & Machine LearningBiotechDeep TechMedical DevicesCoventry, GB
Dr. Joe Healey(Founder)Dr. Nick Waterfield(Founder)Dr. Alexia Hapeshi(Founder)Joe(Founder and former CEO)Nick(Scientific Advisor and Co-founder)Thomas J. Farrell(CEO)
Co-investorsIQ CapitalOctopus VenturesFuture Planet CapitalM Ventures
Biographica (Graphica) uses multi-modal machine learning and high-throughput sequencing to identify and prioritize genetic targets for crop gene-editing, working with trait developers to design effective edits.
AgTechAI & Machine LearningBiotechLondon, GB
Cecy Price(CEO)inDominic Hall(CTO)in
Co-investorsEntrepreneur FirstFaberFaber Capital SCR SASie VenturesSuperSeedCardumen Capital+4 more
Cellbyte automates regulatory workflows and data analysis for pharmaceutical drug launches, helping manufacturers prepare treatments for global markets faster.
AI & Machine LearningEnterprise SoftwareHealthtechMedical DevicesSaaSMunich, DE
Felix Steinbrenner(Co-Founder & CEO)inDanielSamuel
Co-investorsFrontline VenturesPace VenturesY CombinatorSpringboard Health Angels
Converge is an AI-native growth platform for direct-to-consumer brands that automates media buying, attribution analysis, and reporting through agentic AI.
AdTechAI & Machine LearningDirect to ConsumerE-commerceEnterprise SoftwareSaaSNew York City, US
Jan-Henrik Lambrechts(Founder)inJerome Billiet(Founder)inThomas Holvoet(Founder)in
Co-investorsEntourage VenturesY CombinatorBessemer Venture PartnersTLV PartnersVintage Investment Partners
Converge Bio develops generative AI models trained on DNA, RNA, and protein sequences to support drug discovery and development for biotech and pharmaceutical companies.
AI & Machine LearningBiotechDeep TechClaymont, US
Dov Gertz(Executive Officer, Director)inOded Kalev(Executive Officer, Director)inIddo Weiner(Executive Officer)in
BoardShahar Tzafrir(Director)inAndrew Hedin(Director)in
Co-investorsBessemer Venture PartnersTLV PartnersVintage Investment Partners
Parse provides cloud-based backend infrastructure and tools for developers to build applications across mobile, desktop, and embedded platforms, including data storage, push notifications, and usage analytics.
Developer ToolsEnterprise SoftwareSan Francisco, US
Kevin Lacker(Founder/CTO)in
Co-investorsY Combinator
Parse provides an API platform that converts web actions and data retrieval from any website into single API calls without running a browser.
Data & InfrastructureDeveloper ToolsEnterprise SoftwareSaaSSan Francisco, US
Alex Forman(Founder)in
Co-investorsY Combinator
Parse.ly is a content analytics and audience intelligence platform offering a real-time dashboard, a content recommendation API, a data pipeline to warehouses, and AI-driven insights.
Data & InfrastructureMarketing TechMedia & Entertainment
Co-investorsHaatchHorizon Technology FinanceJanus Henderson InvestorsSahsen VenturesSoleus Capital
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.